Literature DB >> 20432590

[Chronic inflammatory bowel disease: Crohn's disease and ulcerative colitis].

R Fiasse1, M A Denis, O Dewit.   

Abstract

Inflammatory bowel diseases comprise Crohn's disease, ulcerative colitis and indeterminate colitis, generally beginning in young subjects and increasing in frequency in Western countries. Despite their still unknown aetiologies, some pathogenic mechanisms have been elucidated after the recent discovery of numerous susceptibility genes and rare environmental factors. These diseases have a course consisting of episodes of flare-up alternating with periods of remission. Medical treatment for induction of a remission comprises besides aminosalicylates, corticosteroids including budesonide and immunosuppressive drugs, anti-TNF-alpha drugs (infliximab, adalimumab) indicated in case of failure of previous therapies. Surgery is indicated for complications and failure of medical treatment.With current therapy, most of the patients are able to fulfil their familial, social and professional projects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20432590

Source DB:  PubMed          Journal:  J Pharm Belg        ISSN: 0047-2166


  2 in total

1.  VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-κB pathway in rat model of DSS-induced colitis.

Authors:  Cong Dai; Chang-Qing Zheng; Fan-Ji Meng; Zheng Zhou; Li-Xuan Sang; Min Jiang
Journal:  Mol Cell Biochem       Date:  2012-10-23       Impact factor: 3.396

2.  Assessment of Patients' Future Outlook after Bowel Resection in Crohn's Disease.

Authors:  Shasha Tang; Xiaolong Ge; Weilin Qi; Wei Liu; Qian Cao; Wei Zhou
Journal:  Gastroenterol Res Pract       Date:  2019-01-09       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.